Russia has invented a 100% effective cancer vaccine

Enteromix, a personalized mRNA cancer vaccine, has shown 100 percent efficacy and safety in trials. Developed by Russian institutes, it is awaiting approval from the Ministry of Health. Only then will it be widely used, writes News 18.

In a potential breakthrough in the fight against cancer, a revolutionary mRNA vaccine called Enteromix has demonstrated 100 percent efficacy and safety in clinical trials. The treatment, which aims to destroy cancer cells and significantly shrink large tumors, is now awaiting final approval from the Ministry of Health before it can be made available to the public.

Developed using advanced mRNA technology similar to that used in COVID-19 vaccines, Enteromix works by training the immune system to recognize and destroy cancer cells. Unlike traditional treatments like chemotherapy or radiation, the vaccine is personalized for each patient. There were no serious side effects reported, and patients tolerated the treatment well.

On the subject: Humanity Beats the Cancer Curse: 7 Innovative Cancer Treatments That Will Change the World

(The principle of operation of an mRNA vaccine is as follows: to fight a virus, for example, a person is given “instructions” in the form of a mRNA molecule instead of a ready-made virus or its weakened form. The body’s cells read these instructions and begin to produce a small fragment of the viral protein for a while. This protein itself is safe, but the immune system recognizes it as foreign and produces protection — antibodies and cells that are capable of destroying cells infected with the virus. Thanks to this, when the body encounters a real virus, it is already prepared and can quickly fight back. It is important that mRNA is not integrated into human DNA and, having fulfilled its function, is destroyed fairly quickly.

In the case of cancer, the principle of mRNA vaccines is used slightly differently than in infectious diseases. If in the case of viruses, instructions are introduced into the body to create a fragment of a viral protein, then in oncology, mRNA carries the code of proteins that are specific to tumor cells.

After the vaccine is administered, the body's cells begin to temporarily synthesize these "tag" proteins. The immune system learns to recognize them as foreign and forms a response against the cells that carry such proteins. Since they are found only on cancer cells, the immune system begins to specifically attack the tumor without damaging healthy tissue.

Thus, the vaccine "teaches" the immune system to see a tumor that it had not noticed before. In addition, such vaccines are often made personalized: they take tumor samples from a specific patient, identify unique mutations, and create individual mRNA instructions for them. – Note.)

Earlier, it was reported that Russia had begun clinical trials of the new Enteromix vaccine involving 48 volunteers. The drug was developed by the National Medical Research Radiological Center of the Russian Ministry of Health in collaboration with the Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences.

The vaccine, while also boosting the patient’s immune system to fight cancer, uses four harmless viruses to attack and destroy cancerous tumors, according to MedPath. Enteromix has undergone years of early testing and has been shown to slow tumor growth and, in some cases, completely eradicate cancer.

You may be interested in: top New York news, stories of our immigrants and helpful tips about life in the Big Apple - read it all on ForumDaily New York

The start of clinical trials was announced at the St. Petersburg International Economic Forum (SPIEF-2025), which was held from June 18 to 21.

Once the trials are successfully completed, the only remaining step is regulatory approval. The Russian Ministry of Health is expected to conduct a final review of the data in the coming weeks.

If approved, Enteromix will be the first personalized mRNA cancer vaccine available to the general public, changing the way cancer is treated and bringing new hope to millions of people.

Read also on ForumDaily:

Guinea pigs or the hope of science: the pros and cons of participating in clinical trials in the US

A nurse from California came to Ukraine to support her fellow oncologists

What to eat to reduce your risk of cancer: doctor's advice

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis.